)
Pay in 4 interest-free payments of $5.99 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
14.5 EXSCEL Cardiovascular Outcomes Trial in Adult Patients with Type 2 Diabetes EXSCEL was a multinational, placebo-controlled, double-blind, randomized, parallel group pragmatic study that evaluated cardiovascular (CV) outcomes during treatment with BYDUREON (exenatide) for extended-release injectable suspension in adult patients with type 2 diabetes and any level of CV risk when added to the current usual care (NCT01144338)
Category Peptide Blends Pre-combined research formulations & stacks
A: According to ro.co (pricing as of November 2025), costs include two components: Membership Fees (separate from medication): First month: $45 Subsequent months: $145/month recurring Medication Costs (separate from membership, varies): Zepbound vials (LillyDirect): $349-$499/month Wegovy pens (NovoCare): $499/month Zepbound pens: ~$1,050/month Ozempic: Varies by pharmacy Insurance copay: $25-$300+ (if approved
If your clinician prefers you stay within one area (for example, abdomen only), rotate different sub-zones of that area each week rather than reusing the same exact spot
Or SubQ protocols where the loading phase drags on for two weeks because peak plasma levels never quite reach the threshold needed to observe the metabolic shift the study was designed to detect
US$ 27.83
US$ 28.23
US$ 22.66
US$ 25.20
US$ 24.83
US$ 21.17
US$ 28.68
US$ 29.35
US$ 22.71
US$ 20.50
US$ 23.76
